US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, Seoul National University Hospital on Jan. 20 for "Composition for preventing or treating diabetes mellitus" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,806, issued on Jan. 20, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea) and Seoul National University Hospital (Seoul, South Korea).

"Composition for preventing or treating diabetes mellitus" was invented by Kyong Soo Park (Seoul, South Korea), Seung-Ah Lee (Gyeonggi-do, South Korea) and Sung Soo Chung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for preventing or treating diabetes mellitus using a 4-component mixture of putrescine, glucosamine, nicotinamide, and a STAT3 inhibitor. It has been confirmed that blood glucose is stably regulated when a co...